Medicine passport
EPCLUSA 400 mg/ 100 mg + 400 mg
The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.
- Active substance
- Velpatasvir + Sofosbuvir
- Strength
- 100 mg + 400 mg
- Form
- comprimé pelliculé
- ATC code
- Not stated by the register
- Registered in
- France · GILEAD SCIENCES IRELAND UC (IRLANDE)
- Prescription
- Prescription only
- CIS
- 63434686
Source: Base de données publique des médicaments · 2026-09-30
Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.
Listed in other countries
United States 2 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| Epclusa | 100 mg + 400 mg · Tablet, Film Coated | Prescription only | Gilead Sciences, Inc. | 61958-2201 |
| Sofosbuvir and Velpatasvir | 100 mg + 400 mg · Tablet, Film Coated | Prescription only | Asegua Therapeutics LLC | 72626-2701 |
Source: NDC Directory (US Food and Drug Administration) · 2026-09-13 · Source: US Food and Drug Administration, NDC Directory.
Same active substance, but no match for this strength and form
- European Union: 1 products · Every strength and form
- Spain: 5 products · Every strength and form
- Canada: 1 products · Every strength and form
- Netherlands: 4 products · Every strength and form